Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jan 11 2021

Full Issue

Tennessee's Medicaid Block Grant Plan OK'd By Outgoing Trump Officials

CMS approved a radically different Medicaid financing system in Tennessee that for the first time would give the state broader authority in running the health insurance program for the poor in exchange for capping its annual federal funding. It's unclear if the Biden administration will allow the move to stand.

Stat: Tennessee To Become First State To Run A Closed Medicaid Drug Formulary

In a first-of-its-kind move, the Trump administration will allow Tennessee officials to restrict medicines covered by the state Medicaid program, which is currently required to provide coverage for all treatments. As part of an effort to overhaul spending by the state program, Tennessee will be permitted to maintain a so-called closed formulary, which is the same approach to coverage taken by private health plans. (Silverman, 1/8)

Tennessean: TennCare Block Grant Given 11th-Hour Approval By Trump Administration

In the waning days of the Trump administration, federal officials approved a plan to convert TennCare funding to a block grant, potentially overhauling the Medicaid program providing health coverage to about one in five Tennesseans. But a TennCare block grant does not align with the health care proposal of President-elect Joe Biden, who instead campaigned on plans to improve and expand Obamacare. Biden may reverse the Tennessee block grant decision before it has any effect. (Kelman, 1/8)

Modern Healthcare: CMS Approves First Medicaid Block Grant

CMS on Friday approved the country's first Medicaid block grant plan in Tennessee, following through on a top priority for CMS Administrator Seema Verma. Under the plan—dubbed "TennCare III"—Tennessee will accept a fixed budget target for its Medicaid program in exchange for more flexibility in spending its Medicaid money and an opportunity to earn shared savings. According to CMS, the agency will work with Tennessee to evaluate historical enrollment and Medicaid cost information to establish a fixed spending target for its Medicaid program. (Brady, 1/8)

KHN: Trump Administration Approves First Medicaid Block Grant, In Tennessee 

The approval is a 10-year “experiment.” Instead of the open-ended federal funding that rises with higher enrollment and health costs, Tennessee will instead get an annual block grant. The approach has been pushed for decades by conservatives who say states too often chafe under strict federal guidelines about enrollment and coverage and can find ways to provide care more efficiently. But under the agreement, Tennessee’s annual funding cap will increase if enrollment grows. What’s different is that unlike other states, federal Medicaid funding in Tennessee won’t automatically keep up with rising per -person Medicaid expenses. (Galewitz, 1/8)

In other Medicaid and Medicare news —

Stat: Democrats, Eyeing Medicare Drug Price Negotiation, Still Face Roadblocks

Democrats have their best shot in more than a decade to deliver on one of the party’s central health care promises: allowing Medicare to directly negotiate prescription drug prices. But it’s far from guaranteed that they can deliver. (Florko and Facher, 1/11)

Cincinnati Enquirer: Ohio Names One Pharmacy Benefit Manager For Medicaid To Save Cash

Ohio's grand quest to finally slay the dragon of overcharges by pharmacy benefit managers starts Monday with the rollout of a new $158 million contract by the state Medicaid agency. The Buckeye State's premise, a unique approach just approved by the federal government: It takes a PBM to beat a PBM. Bearing the sword on behalf of the state is Gainwell Technologies, a single PBM newly hired to work on behalf of Ohio taxpayers. The company will replace the multibillion-dollar conglomerates such as CVS Caremark and Express Scripts that currently serve as middlemen in the prescription drug supply chain for 3 million poor or disabled Ohioans. (Rowland, 1/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF